Generic remedies in the pharmaceutical market: an integrative approach
DOI:
https://doi.org/10.33448/rsd-v11i15.37639Keywords:
Generic drugs; Pharmaceutical market; Drug therapy.Abstract
A generic drug represents a pharmaceutical drug that contains the same chemical substance as a drug originally protected by chemical patents. Generic drugs can be sold after the original drug patents expire. As the active chemical substance is the same, the medical profile of generics is equivalent in performance. Thus, the objective of this research was to verify in the literature in an integrative way the importance of generic drugs in the pharmaceutical market. This is an exploratory, descriptive research, which will be carried out in the form of an integrative literature review and during the search, a total of 250 abstracts were found distributed differently in relation to the databases: Google academic (140), ScieLO (17) and Science Direct (93), leaving 10 articles selected by this study after using the inclusion criteria. The speed of appearance on the market and the acceptance of generics varied according to the pharmacological group. The Generics Law changed the dynamics of the pharmaceutical market. Future studies should examine the ongoing changes in the market as consumers gain greater confidence in generic products and manufacturers develop new marketing strategies.
References
Berndt, E. R., Conti, R. M., & Murphy, S. J. (2017). The landscape of US generic prescription drug markets, 2004-2016 (No. w23640). National Bureau of Economic Research.
da Fonseca, E. M., & Shadlen, K. C. (2017). Promoting and regulating generic medicines: Brazil in comparative perspective. Revista Panamericana de Salud Pública, 41, e5.
Dave, C. V., Kesselheim, A. S., Fox, E. R., Qiu, P., & Hartzema, A. (2017). High generic drug prices and market competition: a retrospective cohort study. Annals of internal medicine, 167(3), 145-151.
Gupta, R., Shah, N. D., & Ross, J. S. (2019). Generic drugs in the United States: policies to address pricing and competition. Clinical Pharmacology & Therapeutics, 105(2), 329-337.
Guttier, M. C., Silveira, M. P. T., Luiza, V. L., & Bertoldi, A. D. (2017). Factors influencing the preference for purchasing generic drugs in a Southern Brazilian city. Revista de saude publica, 51.
Holtkamp, M., & Theodore, W. H. (2018). Generic antiepileptic drugs—safe or harmful in patients with epilepsy?. Epilepsia, 59(7), 1273-1281.
Lee, S. L., Saluja, B., García-Arieta, A., Santos, G. M. L., Li, Y., Lu, S., ... & Lyapustina, S. (2015). Regulatory considerations for approval of generic inhalation drug products in the US, EU, Brazil, China, and India.
Luo, J., Kulldorff, M., Sarpatwari, A., Pawar, A., & Kesselheim, A. S. (2019). Variation in prescription drug prices by retail pharmacy type: a national cross-sectional study. Annals of Internal Medicine, 171(9), 605-611.
Mishuk, A. U., Fasina, I., & Qian, J. (2020). Impact of US federal and state generic drug policies on drug use, spending, and patient outcomes: A systematic review. Research in Social and Administrative Pharmacy, 16(6), 736-745.
Nardi, E. P., & Ferraz, M. B. (2016). Perception of the value of generic drugs in São Paulo, Brazil. Cadernos de Saúde Pública, 32.
Qian, J., Hansen, R. A., Surry, D., Howard, J., Kiptanui, Z., & Harris, I. (2017). Disclosure of industry payments to prescribers: industry payments might be a factor impacting generic drug prescribing. Pharmacoepidemiology and drug safety, 26(7), 819-826.
Ramani, S. V., & Urias, E. (2018). When access to drugs meets catch-up: Insights from the use of CL threats to improve access to ARV drugs in Brazil. Research Policy, 47(8), 1538-1552.
Rome, B. N., Lee, C. C., Gagne, J. J., & Kesselheim, A. S. (2021). Factors associated with generic drug uptake in the United States, 2012 to 2017. Value in Health, 24(6), 804-811.
Socal, M. P., Bai, G., & Anderson, G. F. (2019). Favorable formulary placement of branded drugs in Medicare prescription drug plans when generics are available. JAMA internal medicine, 179(6), 832-833.
Trish, E., Gascue, L., Ribero, R., Van Nuys, K., & Joyce, G. (2021). Comparison of spending on common generic drugs by Medicare vs Costco members. JAMA Internal Medicine, 181(10), 1414-1416.
Verbaanderd, C., Meheus, L., Huys, I., & Pantziarka, P. (2017). Repurposing drugs in oncology: next steps. Trends in cancer, 3(8), 543-546.
Wouters, O. J., Kanavos, P. G., & McKee, M. (2017). Comparing generic drug markets in Europe and the United States: prices, volumes, and spending. The Milbank Quarterly, 95(3), 554-601.
Yang, Y., Hu, R., Geng, X., Mao, L., Wen, X., Wang, Z., ... & Mao, Z. (2022). The impact of National Centralised Drug Procurement policy on the use of policy‐related original and generic drugs in China. The International Journal of Health Planning and Management.
Zhao, L., Kim, M. J., Zhang, L., & Lionberger, R. (2019). Generating model integrated evidence for generic drug development and assessment. Clinical Pharmacology & Therapeutics, 105(2), 338-349.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Márcio Felipe Torres Ferreira Chaves; Tais de Sousa e Sousa ; Antônio Carlos de Carvalho
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
